Patents/Assignees

Akston Biosciences Corporation

10 patents in portfolio

US12606605utility2026
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
0 cites
US12454565utility2025
PD-L1 Analog Fusion Proteins for Antigen Specific Immunotherapy and Methods of Use
0 cites
US12195511utility2025
Ultra-long Acting Insulin-fc Fusion Protein
0 cites
US11919935utility2024
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
0 cites
US11814418utility2023
Ultra-long Acting Insulin-fc Fusion Protein and Methods of Use
0 cites
US11773151utility2023
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
0 cites
US11707517utility2023
Antigen Specific Immunotherapy for COVID-19 Fusion Proteins and Methods of Use
0 cites
US11673934utility2023
Ultra-long Acting Insulin-fc Fusion Proteins and Methods of Use
0 cites
US11667689utility2023
Insulin-fc Fusion Proteins and Methods of Use to Treat Cancer
0 cites
US11555058utility2023
Cells Engineered to Express Ultra-long Acting Insulin-fc Fusion Proteins
0 cites